<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35123284</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1095-8673</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>274</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of surgical research</Title>
          <ISOAbbreviation>J Surg Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Outcomes and Perioperative Nutritional Management in a Porcine Model of Short Bowel Syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>59</StartPage>
          <EndPage>67</EndPage>
          <MedlinePgn>59-67</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2022.01.004</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0022-4804(22)00004-X</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION">Short bowel syndrome (SBS) results from significant intestinal loss and is characterized by insufficient absorption of nutrients and fluids. Preclinical large animal SBS models typically require parenteral nutrition (PN) support and may not be appropriate for studying interventions to improve intestinal absorption or adaptation. Here, we describe the development of a porcine SBS model that does not require PN support.</AbstractText>
          <AbstractText Label="METHODS">Eight male Yorkshire piglets underwent either a 75% or 90% jejunoileal resection (n = 5) or no resection (n = 3). Continuous enteral nutrition (EN) was provided via a gastrostomy tube. The final SBS model consisted of a 75% resection and nutrition provided via combination EN (60%) and per oral pig chow (40%). Body weight and concentration of fat-soluble vitamins were assessed on postoperative days (POD) 7, 14, and 21. For assessing fat malabsorption, the coefficient of fat absorption (CFA) was calculated following a 72-h stool collection.</AbstractText>
          <AbstractText Label="RESULTS">Resected animals had decreased weight gain compared to unresected controls (POD21 + 8.3% versus +28.8%, P = 0.048). Vitamin D concentration was significantly lower in resected animals compared to controls on POD 7, POD 14, and POD 21. Serum vitamin E concentration was also lower on POD 21. Resected animals developed fat malabsorption with lower CFA (76.5% versus 95.3%, P = 0.014).</AbstractText>
          <AbstractText Label="CONCLUSIONS">We describe the development of a porcine SBS model that does not require PN support. Piglets in this model gain less weight, demonstrate fat malabsorption, and develop fat-soluble vitamin deficiencies. This model will benefit investigations of intestinal absorption or adaptation while potentially decreasing costs and confounding complications related to PN administration.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tsikis</LastName>
            <ForeName>Savas Theodore</ForeName>
            <Initials>ST</Initials>
            <AffiliationInfo>
              <Affiliation>Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fligor</LastName>
            <ForeName>Scott C</ForeName>
            <Initials>SC</Initials>
            <AffiliationInfo>
              <Affiliation>Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Secor</LastName>
            <ForeName>Jordan D</ForeName>
            <Initials>JD</Initials>
            <AffiliationInfo>
              <Affiliation>Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Lumeng J</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Amy</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Loring</LastName>
            <ForeName>Greta</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Alcresta Therapeutics, Newton, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>First</LastName>
            <ForeName>Eric</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Alcresta Therapeutics, Newton, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nedder</LastName>
            <ForeName>Arthur P</ForeName>
            <Initials>AP</Initials>
            <AffiliationInfo>
              <Affiliation>Animal Care Resources Children's Hospital, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grammer</LastName>
            <ForeName>Robin M</ForeName>
            <Initials>RM</Initials>
            <AffiliationInfo>
              <Affiliation>Animal Care Resources Children's Hospital, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rudie</LastName>
            <ForeName>Coral</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gura</LastName>
            <ForeName>Kathleen M</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy and the Division of Gastroenterology and Nutrition, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Puder</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: Mark.Puder@childrens.harvard.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>T32 DK007754</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 HL007734</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Surg Res</MedlineTA>
        <NlmUniqueID>0376340</NlmUniqueID>
        <ISSNLinking>0022-4804</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014815">Vitamins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004750" MajorTopicYN="N">Enteral Nutrition</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009752" MajorTopicYN="N">Nutritional Status</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018529" MajorTopicYN="N">Nutritional Support</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010288" MajorTopicYN="N">Parenteral Nutrition</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012778" MajorTopicYN="Y">Short Bowel Syndrome</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Coefficient of fat absorption</Keyword>
        <Keyword MajorTopicYN="Y">Fat-soluble vitamins</Keyword>
        <Keyword MajorTopicYN="Y">Nutritional optimization</Keyword>
        <Keyword MajorTopicYN="Y">Porcine model</Keyword>
        <Keyword MajorTopicYN="Y">Short bowel syndrome</Keyword>
        <Keyword MajorTopicYN="Y">Steatorrhea</Keyword>
      </KeywordList>
      <CoiStatement>Disclosures. <b>Conflicts of Interest</b>: Dr. Puder and Dr. Gura have previously received research support from Alcresta Therapeutics, Inc (Newton, MA). Ms. Rudie is a consultant for Alcresta Therapeutics, Inc. Dr. Loring and Dr. First are employees of Alcresta Therapeutics, Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>20</Hour>
          <Minute>17</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35123284</ArticleId>
        <ArticleId IdType="mid">NIHMS1772829</ArticleId>
        <ArticleId IdType="pmc">PMC9038684</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jss.2022.01.004</ArticleId>
        <ArticleId IdType="pii">S0022-4804(22)00004-X</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Wales PW, de Silva N, Kim J, Lecce L, To T, et al.
Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg
2004:39:690–695.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15137001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boullata JI, Carrera AL, Harvey L, Escuro AA, Hudson L, et al.
ASPEN Safe Practices for Enteral Nutrition Therapy [Formula: see text]. JPEN J Parenter Enteral Nutr
2017:41:15–103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27815525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seddik TB, Tian L, Nespor C, Kerner J, Maldonado Y, et al.
Risk Factors of Ambulatory Central Line-Associated Bloodstream Infection in Pediatric Short Bowel Syndrome. JPEN J Parenter Enteral Nutr
2020:44:500–506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31179578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duro D, Mitchell PD, Kalish LA, Martin C, McCarthy M, et al.
Risk factors for parenteral nutrition-associated liver disease following surgical therapy for necrotizing enterocolitis: A Glaser Pediatric Research Network Study [corrected]. J Pediatr Gastroenterol Nutr
2011:52:595–600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3444282</ArticleId>
            <ArticleId IdType="pubmed">21464752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, et al.
Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology
2012:143:1473–1481 e1473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22982184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slim GM, Lansing M, Wizzard P, Nation PN, Wheeler SE, et al.
Novel Long-Acting GLP-2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum. JPEN J Parenter Enteral Nutr
2019:43:891–898.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30614011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pauline ML, Nation PN, Wizzard PR, Hinchliffe T, Wu T, et al.
Comparing the Intestinotrophic Effects of 2 Glucagon-Like Peptide-2 Analogues in the Treatment of Short-Bowel Syndrome in Neonatal Piglets. JPEN J Parenter Enteral Nutr
2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Lim DW, Turner JM, Wales PW
Emerging Piglet Models of Neonatal Short Bowel Syndrome. JPEN J Parenter Enteral Nutr
2015:39:636–643.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25293943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turner JM, Wales PW, Nation PN, Wizzard P, Pendlebury C, et al.
Novel neonatal piglet models of surgical short bowel syndrome with intestinal failure. J Pediatr Gastroenterol Nutr
2011:52:9–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21119541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paris MC, Fuller PJ, Carstensen B, Nagy E, Taylor RG, et al.
Plasma GLP-2 levels and intestinal markers in the juvenile pig during intestinal adaptation: effects of different diet regimens. Dig Dis Sci
2004:49:1688–1695.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15573929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weih S, Nickkholgh A, Kessler M, Frongia G, Hafezi M, et al.
Models of short bowel syndrome in pigs: a technical review. Eur Surg Res
2013:51:66–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24081112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fine KD, Ogunji FA
new method of quantitative fecal fat microscopy and its correlation with chemically measured fecal fat output. Am J Clin Pathol
2000:113:528–534.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10761454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cromwell GL
Nutritional Requirements of Pigs. Merck Veterinary Manual: Merck, 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Seetharam P, Rodrigues G
Short bowel syndrome: a review of management options. Saudi J Gastroenterol
2011:17:229–235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3133978</ArticleId>
            <ArticleId IdType="pubmed">21727727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borowitz D, Konstan MW, O’Rourke A, Cohen M, Hendeles L, et al.
Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis. J Pediatr Pharmacol Ther
2007:12:47–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3462160</ArticleId>
            <ArticleId IdType="pubmed">23055842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albahrani AA, Greaves RF
Fat-Soluble Vitamins: Clinical Indications and Current Challenges for Chromatographic Measurement. Clin Biochem Rev
2016:37:27–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4810759</ArticleId>
            <ArticleId IdType="pubmed">27057076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goncalves A, Roi S, Nowicki M, Dhaussy A, Huertas A, et al.
Fat-soluble vitamin intestinal absorption: absorption sites in the intestine and interactions for absorption. Food Chem
2015:172:155–160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25442537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim DW, Levesque CL, Vine DF, Muto M, Koepke JR, et al.
Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol
2017:312:G390–G404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28104586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vegge A, Thymann T, Lund P, Stoll B, Bering SB, et al.
Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates. Am J Physiol Gastrointest Liver Physiol
2013:305:G277–285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4073902</ArticleId>
            <ArticleId IdType="pubmed">23764891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua Z, Turner JM, Mager DR, Sigalet DL, Wizzard PR, et al.
Effects of polymeric formula vs elemental formula in neonatal piglets with short bowel syndrome. JPEN J Parenter Enteral Nutr
2014:38:498–506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23690158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua Z, Turner JM, Sigalet DL, Wizzard PR, Nation PN, et al.
Role of glucagon-like peptide-2 deficiency in neonatal short-bowel syndrome using neonatal piglets. Pediatr Res
2013:73:742–749.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23481550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welters CF, Deutz NE, Dejong CH, Soeters PB, Heineman E
Supplementation of enteral nutrition with butyrate leads to increased portal efflux of amino acids in growing pigs with short bowel syndrome. J Pediatr Surg
1996:31:526–529.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8801305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellis ZM, Tan HSG, Embleton ND, Sangild PT, van Elburg RM
Milk feed osmolality and adverse events in newborn infants and animals: a systematic review. Arch Dis Child Fetal Neonatal Ed
2019:104:F333–F340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6764252</ArticleId>
            <ArticleId IdType="pubmed">30523072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chelstowska S, Widjaja-Adhi MA, Silvaroli JA, Golczak M
Molecular Basis for Vitamin A Uptake and Storage in Vertebrates. Nutrients
2016:8.</Citation>
        </Reference>
        <Reference>
          <Citation>Pakarinen MP, Kurvinen A, Gylling H, Miettinen TA, Pesonen M, et al.
Cholesterol metabolism in pediatric short bowel syndrome after weaning off parenteral nutrition. Dig Liver Dis
2010:42:554–559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20538532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ubesie AC, Kocoshis SA, Mezoff AG, Henderson CJ, Helmrath MA, et al.
Multiple micronutrient deficiencies among patients with intestinal failure during and after transition to enteral nutrition. J Pediatr
2013:163:1692–1696.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3842410</ArticleId>
            <ArticleId IdType="pubmed">23978355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang CF, Duro D, Zurakowski D, Lee M, Jaksic T, et al.
High prevalence of multiple micronutrient deficiencies in children with intestinal failure: a longitudinal study. J Pediatr
2011:159:39–44 e31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3112274</ArticleId>
            <ArticleId IdType="pubmed">21324480</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
